Lytic infection of permissive cells with human cytomegalovirus is regulated by an intrinsic ‘pre-immediate-early’ repression of viral gene expression mediated by histone post-translational modification Free

Abstract

Human cytomegalovirus (HCMV) lytic gene expression occurs in a regulated cascade, initiated by expression of the viral major immediate-early (IE) proteins. Transcribed from the major IE promoter (MIEP), the major IE genes regulate viral early and late gene expression. This study found that a substantial proportion of infecting viral genomes became associated with histones immediately upon infection of permissive fibroblasts at low m.o.i. and these histones bore markers of repressed chromatin. As infection progressed, however, the viral MIEP became associated with histone marks, which correlate with the known transcriptional activity of the MIEP at IE time points. Interestingly, this chromatin-mediated repression of the MIEP at ‘pre-IE’ times of infection could be overcome by inhibition of histone deacetylases, as well as by infection at high m.o.i., and resulted in a temporal advance of the infection cycle by inducing premature viral early and late gene expression and DNA replication. As well as the MIEP, and consistent with previous observations, the viral early and late promoters were also initially associated with repressive chromatin. However, changes in histone modifications around these promoters also occurred as infection progressed, and this correlated with the known temporal regulation of the viral early and late gene expression cascade. These data argue that the chromatin structure of all classes of viral genes are initially repressed on infection of permissive cells and that the chromatin structure of HCMV gene promoters plays an important role in regulating the time course of viral gene expression during lytic infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.012526-0
2009-10-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/10/2364.html?itemId=/content/journal/jgv/10.1099/vir.0.012526-0&mimeType=html&fmt=ahah

References

  1. Ahn J. H., Hayward G. S. 1997; The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol 71:4599–4613
    [Google Scholar]
  2. Ahn J. H., Hayward G. S. 2000; Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274:39–55 [CrossRef]
    [Google Scholar]
  3. Bresnahan W. A., Shenk T. E. 2000; UL82 virion protein activates expression of immediate-early viral genes in human cytomegalovirus-infected cells. Proc Natl Acad Sci U S A 97:14506–14511 [CrossRef]
    [Google Scholar]
  4. Cantrell S. R., Bresnahan W. A. 2005; Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication. J Virol 79:7792–7802 [CrossRef]
    [Google Scholar]
  5. Cantrell S. R., Bresnahan W. A. 2006; Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 80:6188–6191 [CrossRef]
    [Google Scholar]
  6. Coleman H. M., Connor V., Cheng Z. S., Grey F., Preston C. M., Efstathiou S. 2008; Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression. J Gen Virol 89:68–77 [CrossRef]
    [Google Scholar]
  7. Compton T. 2000; Analysis of cytomegalovirus ligands, receptors and the entry pathway. In Methods in Molecular Medicine: Cytomegalovirus Protocols pp 53–65Edited by Sinclair. Totowa, NJ: Humana Press;
    [Google Scholar]
  8. Cuevas-Bennett C., Shenk T. 2008; Dynamic histone H3 acetylation and methylation at human cytomegalovirus promoters during replication in fibroblasts. J Virol 82:9525–9536 [CrossRef]
    [Google Scholar]
  9. Depto A. S., Stenberg R. M. 1992; Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis -acting elements and viral trans -acting proteins necessary for promoter activation. J Virol 66:3241–3246
    [Google Scholar]
  10. Dosa R., Burian K., Gonczol E. 2005; Human cytomegalovirus latency is associated with the state of differentiation of the host cells: an in vitro model in teratocarcinoma cells. Acta Microbiol Immunol Hung 52:397–406 [CrossRef]
    [Google Scholar]
  11. Everett R. D., Chelbi-Alix M. K. 2007; PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89:819–830 [CrossRef]
    [Google Scholar]
  12. Fish K. N., Soderberg-Naucler C., Mills L. K., Stenglein S., Nelson J. A. 1998; Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72:5661–5668
    [Google Scholar]
  13. Fortunato E. A., Sanchez V., Yen J. Y., Spector D. H. 2002; Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. J Virol 76:5369–5379 [CrossRef]
    [Google Scholar]
  14. Greaves R. F., Mocarski E. S. 1998; Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus IE1 mutant. J Virol 72:366–379
    [Google Scholar]
  15. Groves I. J., Sinclair J. H. 2007; Knockdown of hDaxx in normally non-permissive undifferentiated cells does not permit human cytomegalovirus immediate-early gene expression. J Gen Virol 88:2935–2940 [CrossRef]
    [Google Scholar]
  16. Hertel L., Lacaille V. G., Strobl H., Mellins E. D., Mocarski E. S. 2003; Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol 77:7563–7574 [CrossRef]
    [Google Scholar]
  17. Hofmann H., Sindre H., Stamminger T. 2002; Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J Virol 76:5769–5783 [CrossRef]
    [Google Scholar]
  18. Hollenbach A. D., McPherson C. J., Mientjes E. J., Iyengar R., Grosveld G. 2002; Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci 115:3319–3330
    [Google Scholar]
  19. Ioudinkova E., Arcangeletti M. C., Rynditch A., De Conto F., Motta F., Covan S., Pinardi F., Razin S. V., Chezzi C. 2006; Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line. Gene 384:120–128 [CrossRef]
    [Google Scholar]
  20. Ishov A. M., Maul G. G. 1996; The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134:815–826 [CrossRef]
    [Google Scholar]
  21. Kondo K., Kaneshima H., Mocarski E. S. 1994; Human cytomegalovirus latent infection of granulocyte–macrophage progenitors. Proc Natl Acad Sci U S A 91:11879–11883 [CrossRef]
    [Google Scholar]
  22. Korioth F., Maul G. G., Plachter B., Stamminger T., Frey J. 1996; The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229:155–158 [CrossRef]
    [Google Scholar]
  23. Kuntz-Simon G., Obert G. 1995; Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication. J Gen Virol 76:1409–1415 [CrossRef]
    [Google Scholar]
  24. Lathey J. L., Spector S. A. 1991; Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J Virol 65:6371–6375
    [Google Scholar]
  25. Li H., Chen J. D. 2000; PML and the oncogenic nuclear domains in regulating transcriptional repression. Curr Opin Cell Biol 12:641–644 [CrossRef]
    [Google Scholar]
  26. Lukashchuk V., McFarlane S., Everett R. D., Preston C. M. 2008; Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J Virol 82:12543–12554 [CrossRef]
    [Google Scholar]
  27. Marshall K. R., Rowley K. V., Rinaldi A., Nicholson I. P., Ishov A. M., Maul G. G., Preston C. M. 2002; Activity and intracellular localization of the human cytomegalovirus protein pp71. J Gen Virol 83:1601–1612
    [Google Scholar]
  28. Maul G. G. 1998; Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20:660–667 [CrossRef]
    [Google Scholar]
  29. Meier J. L., Stinski M. F. 1996; Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 39:331–342
    [Google Scholar]
  30. Mendelson M., Monard S., Sissons P., Sinclair J. 1996; Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 77:3099–3102 [CrossRef]
    [Google Scholar]
  31. Michaelis M., Suhan T., Reinisch A., Reisenauer A., Fleckenstein C., Eikel D., Gumbel H., Doerr H. W., Nau H., Cinatl J. Jr 2005; Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Invest Ophthalmol Vis Sci 46:3451–3457 [CrossRef]
    [Google Scholar]
  32. Morris D. P., Michelotti G. A., Schwinn D. A. 2005; Evidence that phosphorylation of the RNA polymerase II carboxyl-terminal repeats is similar in yeast and humans. J Biol Chem 280:31368–31377 [CrossRef]
    [Google Scholar]
  33. Murphy J. C., Fischle W., Verdin E., Sinclair J. H. 2002; Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J 21:1112–1120 [CrossRef]
    [Google Scholar]
  34. Nevels M., Paulus C., Shenk T. 2004; Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc Natl Acad Sci U S A 101:17234–17239 [CrossRef]
    [Google Scholar]
  35. Nitzsche A., Paulus C., Nevels M. 2008; Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J Virol 82:11167–11180 [CrossRef]
    [Google Scholar]
  36. Park J. J., Kim Y. E., Pham H. T., Kim E. T., Chung Y. H., Ahn J. H. 2007; Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts. J Gen Virol 88:3214–3223 [CrossRef]
    [Google Scholar]
  37. Preston C. M., Nicholl M. J. 2006; Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol 87:1113–1121 [CrossRef]
    [Google Scholar]
  38. Reeves M. B., Lehner P. J., Sissons J. G., Sinclair J. H. 2005a; An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol 86:2949–2954 [CrossRef]
    [Google Scholar]
  39. Reeves M. B., MacAry P. A., Lehner P. J., Sissons J. G., Sinclair J. H. 2005b; Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102:4140–4145 [CrossRef]
    [Google Scholar]
  40. Reeves M., Murphy J., Greaves R., Fairley J., Brehm A., Sinclair J. 2006; Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86. J Virol 80:9998–10009 [CrossRef]
    [Google Scholar]
  41. Riegler S., Hebart H., Einsele H., Brossart P., Jahn G., Sinzger C. 2000; Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol 81:393–399
    [Google Scholar]
  42. Saffert R. T., Kalejta R. F. 2006; Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80:3863–3871 [CrossRef]
    [Google Scholar]
  43. Schneider R., Bannister A. J., Myers F. A., Thorne A. W., Crane-Robinson C., Kouzarides T. 2004; Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6:73–77 [CrossRef]
    [Google Scholar]
  44. Sindre H., Tjoonnfjord G. E., Rollag H., Ranneberg-Nilsen T., Veiby O. P., Beck S., Degre M., Hestdal K. 1996; Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 88:4526–4533
    [Google Scholar]
  45. Sinzger C., Grefte A., Plachter B., Gouw A. S., The T. H., Jahn G. 1995; Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76:741–750 [CrossRef]
    [Google Scholar]
  46. Spector D. H. 1996; Activation and regulation of human cytomegalovirus 1 early genes. Intervirology 39:361–377
    [Google Scholar]
  47. Stillman B. 1986; Chromatin assembly during SV40 DNA replication in vitro . Cell 45:555–565 [CrossRef]
    [Google Scholar]
  48. Sugasawa K., Murakami Y., Miyamoto N., Hanaoka F., Ui M. 1990; Assembly of nascent DNA into nucleosome structures in simian virus 40 chromosomes by HeLa cell extract. J Virol 64:4820–4829
    [Google Scholar]
  49. Tang Q., Maul G. G. 2003; Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J Virol 77:1357–1367 [CrossRef]
    [Google Scholar]
  50. Tavalai N., Papior P., Rechter S., Leis M., Stamminger T. 2006; Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80:8006–8018 [CrossRef]
    [Google Scholar]
  51. Tavalai N., Papior P., Rechter S., Stamminger T. 2008; Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82:126–137 [CrossRef]
    [Google Scholar]
  52. Trojer P., Reinberg D. 2007; Facultative heterochromatin: is there a distinctive molecular signature?. Mol Cell 28:1–13 [CrossRef]
    [Google Scholar]
  53. Varnum S. M., Streblow D. N., Monroe M. E., Smith P., Auberry K. J., Pasa-Tolic L., Wang D., Camp D. G., II, Rodland K. other authors 2004; Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78:10960–10966 [CrossRef]
    [Google Scholar]
  54. Wathen M. W., Stinski M. F. 1982; Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol 41:462–477
    [Google Scholar]
  55. Wiebusch L., Asmar J., Uecker R., Hagemeier C. 2003; Human cytomegalovirus immediate-early protein 2 (IE2)-mediated activation of cyclin E is cell-cycle independent and forces S-phase entry in IE2-arrested cells. J Gen Virol 84:51–60 [CrossRef]
    [Google Scholar]
  56. Wilkinson G. W., Kelly C., Sinclair J. H., Rickards C. 1998; Disruption of PML8 associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J Gen Virol 79:1233–1245
    [Google Scholar]
  57. Woodhall D. L., Groves I. J., Reeves M. B., Wilkinson G., Sinclair J. H. 2006; Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem 281:37652–37660 [CrossRef]
    [Google Scholar]
  58. Wu W. S., Vallian S., Seto E., Yang W. M., Edmondson D., Roth S., Chang K. S. 2001; The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol 21:2259–2268 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.012526-0
Loading
/content/journal/jgv/10.1099/vir.0.012526-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed